X’PROCHEM joins COVID-19 Virtual Partnering initiative organized by Inova. With our proprietary chemical synthesis of

Biological medicines, and anticancer biologicals in particular, represent a growing burden for healthcare budgets. As

X’PROCHEM is proud to announce the acquisition of a new Liquid Chromatography / Mass Spectrometer